Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
Transarterial chemoembolization (TACE) is the treatment of choice for the intermediate stage hepatocellular carcinoma (HCC). Doxorubicin remains the most used chemotherapeutic agent in TACE, although in vitro screening has demonstrated that idarubicin exhibits greater cytotoxicity against HCC. This...
Saved in:
Main Authors: | Korsic Spela, Osredkar Josko, Smid Alojz, Steblovnik Klemen, Popovic Mark, Locatelli Igor, Trontelj Jurij, Popovic Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-10-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2024-0052 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01) -
Multiple acute complications of transarterial chemoembolization of liver metastases
by: R. N. Abu Shamsia, et al.
Published: (2024-12-01) -
Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01) -
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01) -
Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI)
by: Hai-Dong Zhu, et al.
Published: (2024-12-01)